Recent News

• 12.01.2025 - Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 11.04.2025 - Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 11.03.2025 - Solid Biosciences Reports Third Quarter 2025 Financial Results and Provides Update on INSPIRE DUCHENNE Clinical Trial Progress and Planned Regulatory Discussions
• 10.30.2025 - Solid Biosciences to Participate at Upcoming Investor Conferences
• 10.01.2025 - Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 10.01.2025 - Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 10.01.2025 - Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 10.01.2025 - Solid Biosciences to Present at Upcoming Scientific Meetings
• 10.01.2025 - Solid Biosciences to Present at Upcoming Scientific Meetings
• 10.01.2025 - Solid Biosciences to Present at Upcoming Scientific Meetings

Recent Filings

• 11.13.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.13.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 11.03.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.03.2025 - 8-K Current report
• 11.03.2025 - EX-99.1 EX-99.1
• 10.21.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.07.2025 - 4 Statement of changes in beneficial ownership of securities